Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Kazuhiro Sentani"'
Autor:
Kazuhiro Sentani, Wataru Yasui, Shintaro Akabane, Koki Sato, Masatoshi Kochi, Yuji Takakura, Kazuhiro Taguchi, Hiroyuki Egi, Wataru Shimizu, Hideki Ohdan, Ikki Nakashima, Minoru Hattori
Publikováno v:
International Journal of Clinical Oncology. 26:1285-1292
Tumor budding (TB) has been described as an adverse prognostic marker for operable colorectal cancer (CRC); however, a limited number of studies have demonstrated the prognostic significance of TB in patients with drug therapy. This study was conduct
Autor:
Kentaro Ide, Naohide Oue, Yusuke Sumi, Minoru Hattori, Hiroyuki Egi, Kazuhiro Sentani, Wataru Yasui, Hiroyuki Sawada, Haruki Sada, Hideki Ohdan
Publikováno v:
Surgery Today. 51:1860-1871
Acute peritonitis has remained a fatal disease despite of recent advances in care and treatment, including antibiotic and anticoagulant treatments. The cause of death is mostly sepsis-induced multiple organ failure. Oxidative stress can play an impor
Autor:
Yuki Kohada, Kazuma Yukihiro, Jun Teishima, Peter C. Black, Akio Matsubara, Keisuke Goto, Takashi Nishisaka, Kazuhiro Sentani, Mitsuru Kajiwara, Shinya Ohara, Wataru Yasui, Tetsutaro Hayashi, Shogo Inoue, Ryan S. Hsi
Publikováno v:
BJU International. 127:473-485
OBJECTIVES To assess the change in rates of recurrence-free survival (RFS) and progression-free survival (PFS) based on the duration of survival without recurrence or progression among patients with intermediate-risk (IR) non-muscle-invasive bladder
Autor:
Takashi Babasaki, Hiroyuki Kitano, Ryoken Yamanaka, Keisuke Hieda, Yohei Sekino, Akio Matsubara, Kenichiro Ikeda, Tetsutaro Hayashi, Wataru Yasui, Kazuaki Chayama, Jun Teishima, Kazuhiro Sentani, Shogo Inoue, Hiroshi Aikata, Keisuke Goto
Publikováno v:
Int Cancer Conf J
We report a rare case of renal metastasis from primary hepatocellular carcinoma (HCC). A mass in the right kidney of a 71-year-old man was detected by follow-up computed tomography (CT) for HCC. He was diagnosed as having primary HCC 18 years ago and
Autor:
Jun Teishima, Yohei Sekino, Hiroyuki Kitano, Yukiko Honda, Akio Matsubara, Kousuke Sadahide, Keisuke Goto, Wataru Yasui, Tetsutaro Hayashi, Kazuo Awai, Kazuhiro Sentani, Shogo Inoue
Publikováno v:
Japanese Journal of Clinical Oncology. 50:473-478
ObjectivesPrevious studies have reported that cases with clinical T1 renal cell cancer upstaging to pathological T3 are a risk factor to predicting postoperative recurrence after partial nephrectomy. The aim of our study was to investigate the impact
Autor:
Makoto Iida, Kazuhiro Sentani, Jun Teishima, Yukiko Honda, Yuko Nakamura, Motonori Akagi, Keisuke Goto, Keigo Narita, Toru Higaki, Akio Matsubara, Shinsuke Fujii, Tetsutaro Hayashi, Kazuo Awai, Hiroaki Terada, Wataru Yasui, Yoko Kaichi
Publikováno v:
International Journal of Urology. 26:1024-1032
Upper urinary tract urothelial carcinoma is staged using the TNM classification of malignant tumors. Preoperative TNM is important for treatment planning. Computed tomography urography is now widely used for clinical survey of upper urinary tract car
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy
Autor:
Yves Pommier, Yohei Sekino, Wataru Yasui, Takashi Babasaki, Kenji Harada, Naoya Sakamoto, Ryota Maruyama, Kazuhiro Sentani, Masahiko Takeda, Junko Murai, Daiki Taniyama, Quoc Thang Pham, Tsuyoshi Takashima, Shoichi Ukai, Tetsutaro Hayashi
Publikováno v:
Cancer science. 113(2)
The utility of Schlafen 11 (SLFN11) expression as a predictive biomarker for platinum-based chemotherapy has been established for cancers from different histologies. However, the therapeutic relevance of SLFN11 in bladder cancer (BC) is unknown. Here
Autor:
Kenichiro Ikeda, Masanobu Shigeta, Kenshiro Takemoto, Hiroyuki Kitano, Jun Teishima, Daiki Taniyama, Daiki Murata, Mayumi Kaneko, Kazuya Kuraoka, Keisuke Goto, Naohide Oue, Kazuhiro Sentani, Yohei Sekino, Shogo Inoue, Takashi Babasaki, Tetsutaro Hayashi, Kohei Kobatake, Koji Mita
Publikováno v:
Anticancer research. 41(10)
BACKGROUND/AIM Sunitinib continues to be administered as a first-line therapeutic agent in metastatic renal cell carcinoma (mRCC). This study examined the potential role of p53 in sunitinib resistance and as a predictive marker in mRCC. MATERIALS AND
Autor:
Keisuke Matsuo, Hidehiko Takigawa, Satoshi Masaki, Yuji Urabe, Toshikatsu Naito, Taiji Matsuo, Kazuhiro Sentani, Kazuaki Chayama, Yasuhiko Kitadai, Shinji Tanaka, Ryo Yuge
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 9, Pp 4370-4379 (2019)
Cancer Medicine, Vol 8, Iss 9, Pp 4370-4379 (2019)
Most patients with gastric mucosa‐associated lymphoid tissue (MALT) lymphoma are infected with Helicobacter pylori, and eradication therapy is the first‐line treatment for localized disease with H pylori infection. However, there were several rep
Autor:
Naoto Kuroda, Kosuke Sadahide, Shinsuke Fuji, Hiroyuki Shikuma, Masayuki Muto, Jun Teishima, Tetsutaro Hayashi, Shunsuke Shinmei, Yohei Sekino, Akio Matsubara, Kazuhiro Sentani, Keisuke Goto, Tomoya Hatayama, Sakurako Mukai, Wataru Yasui, Shunsuke Miyamoto, Keisuke Hieda, Kenichiro Fukuoka, Shogo Inoue
Publikováno v:
IJU Case Reports
IJU Case Reports, Vol 2, Iss 4, Pp 193-196 (2019)
IJU Case Reports, Vol 2, Iss 4, Pp 193-196 (2019)
Introduction Renal mucinous tubular and spindle cell carcinoma is a rare subtype of renal cell carcinoma newly added to the World Health Organization classification in 2004. Although it has been considered as a tumor with good prognosis, aggressive c